These are Vir Biotechnology VIR, Galapagos NV GLPG and Pacira BioSciences, Inc. PCRX. Click to get this free report GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report Pacira BioSciences, Inc. (PCRX) : Free Stock Analysis Report Galapagos NV (GLPG) : Free Stock Analysis Report Vir Biotechnology, Inc. (VIR) : Free Stock Analysis Report To read this article on Zacks.com click here. The drug and the biotech sector took a beating in 2022, despite showing signs of revival early on, as increasing interest rates, rising inflation and an uncertain macro environment had an adverse impact on major economies.